Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kirtane AJ et al. – One–year clinical outcomes were similar among DM patients treated with ZES and PES in the ENDEAVOR IV trial. These findings parallel the overall trial results, which demonstrated similar efficacy and safety of ZES and PES for single de novo coronary lesions.

Related Articles

ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus
Blood Coagulation & Fibrinolysis, 11/03/09    Relevance Score: 71%

Hepatic fat and inflammation in type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09    Relevance Score: 70%

Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using 13C nuclear magnetic resonance spectroscopy
Metabolism-Clinical and Experimental, 10/13/09    Relevance Score: 70%

Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus
Fertility and Sterility, 10/08/09    Relevance Score: 70%

So Just What Can I Eat? Nutritional Care in Patients with Diabetes Mellitus and Chronic Kidney Disease
Nephrology Nursing Journal, 10/06/09    Relevance Score: 70%

Today in Diabetes...keeping you current

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 11/30/09

Are Hemoglobin Levels Elevated in Type 1 Diabetes
Diabetes Care, 11/30/09

Depression and Advanced Complications of Diabetes: a Prospective Cohort Study
Diabetes Care, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address